IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
about
Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends.Isocitrate dehydrogenase mutations in myeloid malignancies.IDH mutations in cancer and progress toward development of targeted therapeutics.Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia.Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy
P2860
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
@ast
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
@en
type
label
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
@ast
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
@en
prefLabel
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
@ast
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
@en
P2093
P2860
P356
P1433
P1476
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
@en
P2093
C D DiNardo
G Garcia-Manero
H Kantarjian
K Takahashi
M Routbort
P2860
P2888
P304
P356
10.1038/LEU.2015.211
P577
2015-07-31T00:00:00Z